InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Bartram Richard, Chief Financial Officer. Insider active across 2 companies, notably Esperion Therapeutics, Inc.. In total, 3 reports have been recorded. History available since 29 October 2021. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bartram Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
15,000 shares0Common StockSEC:0001193125-26-035584:0
37,000 shares0Common StockSEC:0001628280-22-006408:0
18,700 shares0Common StockSEC:0001628280-21-021008:0
3 of 3 declarations
About Bartram Richard
Richard Bartram is the Chief Financial Officer at Esperion Therapeutics, Inc. He is responsible for managing the company's finances, including accounting, financial planning, and financial reporting.
